Microfilaricidal effect of amocarzine in skin punch biopsies of patients with onchocerciasis from Latin America.
Skin punch biopsies were performed in 54 selected patients with onchocerciasis participating in a clinical trial with amocarzine (CGP 6140) in Ecuador and Guatemala. Skin snipping for counting microfilariae of Onchocerca volvulus was done before treatment (day 0) and day 4 and 8 following start of the therapy which consisted of 3 mg/kg amocarzine postprandially twice daily for three consecutive days. The mean microfilarial skin density has been reduced by 45% on day 4 and 95% on day 8. Skin punch biopsies were taken on day 5, within 1 cm from the snip site on the iliac crest. Histopathologic examination revealed that the vast majority of the microfilariae in the upper as well as in the deeper dermis were degenerated or necrotic, surrounded often (57%) by minute foci of fibrinoid change of the collagen. There was usually slight, less frequently moderate eosinophilic, lympho-plasmocytic and initial histocytic inflammatory reaction in the vicinity. Microfilariae were frequently (69%) found at the dermal-epidermal junction and in the epidermis. Occasionally (7%) intra-epidermal microabscesses were noted. Microfilariae were detected also in the lumen of some dermal lymphatic vessels. Therefore it is concluded that amocarzine showed marked microfilaricidal effects in the skin of patients with onchocerciasis as evidenced histologically by mainly destroyed or moribund microfilariae which induced a mild to moderate inflammatory cell reaction.
Zak
F
F
CIBA-GEIGY Limited, Basle, Switzerland.
Guderian
R
R
Zea-Flores
G
G
Guevara
A
A
Moran
M
M
Poltera
A A
AA
D000328:Adult; D000818:Animals; D001707:Biopsy, Needle; D004484:Ecuador; D004817:Epidermis / Q000469:parasitology; D005260:Female; D006166:Guatemala; D006801:Humans; D008297:Male; D008842:Microfilariae / Q000187:drug effects; D009854:Onchocerca / Q000187:drug effects*; D009855:Onchocerciasis / Q000188:drug therapy* / Q000469:parasitology; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000469:parasitology*
D010879:Piperazines; C051744:amocarzine